Nothing Special   »   [go: up one dir, main page]

NO20055417D0 - Farmasoytisk blanding inneholdene histon-deacetylaseinhibitor - Google Patents

Farmasoytisk blanding inneholdene histon-deacetylaseinhibitor

Info

Publication number
NO20055417D0
NO20055417D0 NO20055417A NO20055417A NO20055417D0 NO 20055417 D0 NO20055417 D0 NO 20055417D0 NO 20055417 A NO20055417 A NO 20055417A NO 20055417 A NO20055417 A NO 20055417A NO 20055417 D0 NO20055417 D0 NO 20055417D0
Authority
NO
Norway
Prior art keywords
pharmaceutical composition
composition containing
histone deacetylase
deacetylase inhibitor
containing histone
Prior art date
Application number
NO20055417A
Other languages
English (en)
Other versions
NO20055417L (no
Inventor
Osamu Nakanishi
Tatsuo Sugawara
Hideyuki Migita
Yasuhiro Matsuba
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of NO20055417D0 publication Critical patent/NO20055417D0/no
Publication of NO20055417L publication Critical patent/NO20055417L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4406—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 3, e.g. zimeldine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pyridine Compounds (AREA)
NO20055417A 2003-05-26 2005-11-16 Farmasoytisk blanding inneholdene histon-deacetylaseinhibitor NO20055417L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2003148073 2003-05-26
PCT/JP2004/007562 WO2004103369A1 (en) 2003-05-26 2004-05-26 Pharmaceutical composition containing histone deacetylase inhibitor

Publications (2)

Publication Number Publication Date
NO20055417D0 true NO20055417D0 (no) 2005-11-16
NO20055417L NO20055417L (no) 2005-12-19

Family

ID=33475383

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20055417A NO20055417L (no) 2003-05-26 2005-11-16 Farmasoytisk blanding inneholdene histon-deacetylaseinhibitor

Country Status (27)

Country Link
US (1) US20070098816A1 (no)
EP (1) EP1626719A1 (no)
JP (1) JP2006526031A (no)
KR (1) KR100938712B1 (no)
CN (2) CN101322707A (no)
AR (1) AR045318A1 (no)
AU (1) AU2004241873C1 (no)
BR (1) BRPI0410959A (no)
CA (4) CA2634765A1 (no)
CL (1) CL2004001278A1 (no)
CO (1) CO5660262A2 (no)
CR (1) CR8163A (no)
CU (1) CU23490B7 (no)
EC (1) ECSP056253A (no)
IL (1) IL171941A0 (no)
ME (1) MEP32308A (no)
MX (1) MXPA05012345A (no)
NO (1) NO20055417L (no)
NZ (1) NZ543591A (no)
PE (1) PE20050206A1 (no)
RS (1) RS20050884A (no)
RU (1) RU2322971C2 (no)
TW (1) TW200505424A (no)
UA (1) UA81499C2 (no)
UY (1) UY28330A1 (no)
WO (1) WO2004103369A1 (no)
ZA (1) ZA200509515B (no)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6777217B1 (en) 1996-03-26 2004-08-17 President And Fellows Of Harvard College Histone deacetylases, and uses related thereto
US20030129724A1 (en) 2000-03-03 2003-07-10 Grozinger Christina M. Class II human histone deacetylases, and uses related thereto
US7244853B2 (en) 2001-05-09 2007-07-17 President And Fellows Of Harvard College Dioxanes and uses thereof
SI2263694T1 (sl) * 2003-09-25 2013-09-30 Astellas Pharma Inc. Antitumorsko sredstvo, ki obsega inhibitor histon-deacetilaze FK228 in inhibitor topoizomeraze II doksorubicin
US7446126B2 (en) * 2004-10-08 2008-11-04 Indena S.P.A. Semisynthesis process for the preparation of 10-deacetyl-N-debenzoyl-paclitaxel
EP1712552A1 (en) * 2005-04-11 2006-10-18 INDENA S.p.A. Semisynthesis process for the preparation of 10-deacetyl-n-debenzoyl-paclitaxel
BRPI0608039A2 (pt) * 2005-03-11 2009-06-16 Univ Colorado células cancerìgenas sensìveis aos inibidores da histona deacetilase
EP2491926B1 (en) 2005-03-22 2018-05-09 President and Fellows of Harvard College Treatment of protein degradation disorders
ZA200800901B (en) 2005-07-14 2010-05-26 Takeda San Diego Inc Histone deacetylase inhibitors
CN101528679A (zh) 2006-02-14 2009-09-09 哈佛大学校长及研究员协会 组蛋白去乙酰化酶抑制剂
CN101400362B (zh) 2006-02-14 2016-10-12 哈佛大学校长及研究员协会 双官能组蛋白去乙酰化酶抑制剂
JP5497431B2 (ja) 2006-05-03 2014-05-21 プレジデント アンド フェローズ オブ ハーバード カレッジ ヒストンデアセチラーゼおよびチューブリンデアセチラーゼ阻害剤
GB0625283D0 (en) * 2006-12-19 2007-01-24 Cyclacel Ltd Combination
PT2099442E (pt) 2006-12-26 2015-02-10 Pharmacyclics Inc Métodos de utilização de inibidores de histona desacetilase e monitorização de biomarcadores em terapia de combinação
US20090131367A1 (en) * 2007-11-19 2009-05-21 The Regents Of The University Of Colorado Combinations of HDAC Inhibitors and Proteasome Inhibitors
CN101970399A (zh) * 2007-12-14 2011-02-09 乔治敦大学 组蛋白脱乙酰酶抑制剂
EP2321264B1 (en) 2008-07-23 2016-05-04 President and Fellows of Harvard College Deacetylase inhibitors and uses thereof
GB2462893B (en) * 2008-08-29 2010-10-13 Bayer Schering Pharma Ag N-(2-aminophenyl)-4-[N-(pyridine-3-yl)-methoxycarbonyl-aminomethyl]-benzamide (MS-275) polymorph B
KR101073760B1 (ko) * 2008-08-29 2011-10-13 바이엘 파마 악티엔게젤샤프트 Ｎ-（2-아미노페닐）-4-［ｎ-（피리딘-3-일）-메톡시카르보닐-아미노메틸］-벤즈아미드 （ｍｓ-275） 다형체 ｂ
HUE036068T2 (hu) 2008-12-19 2018-06-28 Vertex Pharma ATR kináz gátlószereiként alkalmazható pirazinszármazékok
US20120034302A1 (en) * 2009-02-11 2012-02-09 Liangping Yu Particulate composition and the method of making the same
BRPI1009919A2 (pt) * 2009-05-01 2017-03-28 Oncozyme Pharma Inc combinações de pentamidina para tratamento de câncer.
WO2010144371A1 (en) * 2009-06-08 2010-12-16 Gilead Colorado, Inc. Alkanoylamino benzamide aniline hdac inihibitor compounds
WO2011019393A2 (en) 2009-08-11 2011-02-17 President And Fellows Of Harvard College Class- and isoform-specific hdac inhibitors and uses thereof
WO2011025838A1 (en) * 2009-08-25 2011-03-03 Abraxis Bioscience, Llc Combination therapy with nanoparticle compositions of taxane and hedgehog inhibitors
MX2012013081A (es) 2010-05-12 2013-05-09 Vertex Pharma Compuestos utiles como inhibidores de cinasa atr.
EP2755648B1 (en) 2011-09-13 2017-03-08 Pharmacyclics LLC Formulations of histone deacetylase inhibitor in combination with bendamustine and uses thereof
CA3089792C (en) * 2011-09-30 2023-03-14 Vertex Pharmaceuticals Incorporated Treating non-small cell lung cancer with atr inhibitors
RU2677292C2 (ru) 2011-09-30 2019-01-16 Вертекс Фармасьютикалз Инкорпорейтед Способы получения соединений, которые можно использовать в качестве ингибиторов киназы atr
WO2013085902A1 (en) * 2011-12-05 2013-06-13 The University Of Texas M.D. Combination therapy methods for treating an inflammatory breast cancer
US20140044802A1 (en) 2012-04-05 2014-02-13 Vertex Pharmaceuticals Incorporated Compounds useful as inhibitors of atr kinase and combination therapies thereof
WO2014055756A1 (en) 2012-10-04 2014-04-10 Vertex Pharmaceuticals Incorporated Method for measuring atr inhibition mediated increases in dna damage
CA2903473A1 (en) 2013-03-12 2014-10-09 Quanticel Pharmaceuticals, Inc. Histone demethylase inhibitors
US9963452B2 (en) * 2013-03-14 2018-05-08 Augusta Pharmaceuticals Inc. Methods, compounds, and compositions for inhibition of ROS
WO2015127227A1 (en) * 2014-02-21 2015-08-27 Cleveland Biolabs, Inc. Uses of flagellin for improved chemotherapy
US9758517B2 (en) 2014-09-17 2017-09-12 Celgene Quanticel Research, Inc. Histone demethylase inhibitors
WO2017059357A1 (en) 2015-09-30 2017-04-06 Vertex Pharmaceuticals Incorporated Method for treating cancer using a combination of dna damaging agents and atr inhibitors
TWI794171B (zh) 2016-05-11 2023-03-01 美商滬亞生物國際有限公司 Ｈｄａｃ抑制劑與ｐｄ-ｌ１抑制劑之組合治療
TWI808055B (zh) 2016-05-11 2023-07-11 美商滬亞生物國際有限公司 Hdac 抑制劑與 pd-1 抑制劑之組合治療
US11596612B1 (en) 2022-03-08 2023-03-07 PTC Innovations, LLC Topical anesthetics

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2697752B1 (fr) * 1992-11-10 1995-04-14 Rhone Poulenc Rorer Sa Compositions antitumorales contenant des dérivés du taxane.
JP3354090B2 (ja) * 1996-09-30 2002-12-09 シエーリング アクチエンゲゼルシャフト 分化誘導剤
US6794392B1 (en) * 1996-09-30 2004-09-21 Schering Aktiengesellschaft Cell differentiation inducer
US6174905B1 (en) * 1996-09-30 2001-01-16 Mitsui Chemicals, Inc. Cell differentiation inducer
US5753637A (en) * 1996-10-09 1998-05-19 Ideal Ideas, Inc. Method of treating acne conditions
JP2002525320A (ja) * 1998-09-25 2002-08-13 ワーナー−ランバート・カンパニー アセチルジナリンとジェムシタビン、キャペシタビンまたはシスプラチンの組み合わせによる癌の化学療法
JP4509395B2 (ja) * 1999-04-27 2010-07-21 田辺三菱製薬株式会社 肝臓疾患の予防治療薬
EP1229916A2 (en) * 1999-11-10 2002-08-14 Warner-Lambert Company Combination chemotherapy
US6905669B2 (en) * 2001-04-24 2005-06-14 Supergen, Inc. Compositions and methods for reestablishing gene transcription through inhibition of DNA methylation and histone deacetylase
CZ20022216A3 (cs) * 2001-07-02 2003-05-14 Warner-Lambert Company Kombinační chemoterapie
JP2003137866A (ja) * 2001-11-01 2003-05-14 Sankyo Co Ltd フェニレンジアミン誘導体

Also Published As

Publication number Publication date
AU2004241873B8 (en) 2008-05-29
KR100938712B1 (ko) 2010-01-25
ECSP056253A (es) 2006-10-25
MEP32308A (en) 2010-10-10
US20070098816A1 (en) 2007-05-03
KR20060009371A (ko) 2006-01-31
ZA200509515B (en) 2006-07-26
UA81499C2 (en) 2008-01-10
NO20055417L (no) 2005-12-19
TW200505424A (en) 2005-02-16
CA2634765A1 (en) 2004-12-02
AU2004241873C1 (en) 2009-01-22
CL2004001278A1 (es) 2005-05-06
RU2322971C2 (ru) 2008-04-27
PE20050206A1 (es) 2005-03-26
WO2004103369A1 (en) 2004-12-02
MXPA05012345A (es) 2006-02-08
UY28330A1 (es) 2004-12-31
RS20050884A (en) 2008-04-04
AU2004241873B2 (en) 2008-05-08
RU2005140570A (ru) 2006-06-10
CA2527191A1 (en) 2004-12-02
AU2004241873A1 (en) 2004-12-02
AR045318A1 (es) 2005-10-26
CA2634766A1 (en) 2004-12-02
EP1626719A1 (en) 2006-02-22
NZ543591A (en) 2009-09-25
CO5660262A2 (es) 2006-07-31
CU23490B7 (es) 2010-02-23
IL171941A0 (en) 2006-04-10
JP2006526031A (ja) 2006-11-16
CN1794991A (zh) 2006-06-28
CN101322707A (zh) 2008-12-17
CR8163A (es) 2006-07-14
CA2634709A1 (en) 2004-12-02
BRPI0410959A (pt) 2006-07-04

Similar Documents

Publication Publication Date Title
NO20055417D0 (no) Farmasoytisk blanding inneholdene histon-deacetylaseinhibitor
ATE473005T1 (de) Histone-deacetylase-inhibitoren
ATE354366T1 (de) Histondeacetylase-hemmer
DK1495002T3 (da) Benzamide derivatives useful as histone deacetylase inhibitors
ATE395343T1 (de) Sulfonylderivate als histone-deacetylase- inhibitoren
PL378181A1 (pl) Pochodne kwasu hydroksamidowego jako inhibitory deacetylazy histonowej (HDAC)
HK1080465A1 (zh) 作為組蛋白脫乙酰酶新穎抑制劑的磺酰基氨基衍生物
PL374970A1 (en) Substituted thienyl-hydroxamic acids as histone deacetylase inhibitors
IS7714A (is) Lyfjasamsetningar úr módafíníl
DK1354873T3 (da) Perindoaprilsalt og farmaceutiske sammensætninger indeholdende dette
IS7715A (is) Nýjar lyfjasamsetningar úr módafíníl
AU2003286249A8 (en) Histone deacetylase inhibitors
EP1408946A4 (en) HISTONE DEACETYLASE INHIBITORS
NO20032183D0 (no) Histon-deacetylase inhibitor og anvendelse derav
NO20044164L (no) Farmasoytiske sammensetninger
PT1467737E (pt) Composicao farmaceutica orodispersivel de piribedil
TWI346661B (en) Inhibitors of histone deacetylase
DK1301184T3 (da) Valproinsyre og derivater deraf som histondeacetylaseinhibitorer
ITMI20030705A1 (it) Composizione farmaceutica contenente n-acetil-l-cisteina
DOP2002000508A (es) Composición farmaceutica
ITFI20050240A1 (it) Aril ossadiazoli inibitori dell'istone deacelitasi e formulazioni farmaceutiche che li contengono
ITMI20020926A1 (it) Composizioni farmaceutiche riepitelizzanti

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application